• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中神经元ERK、JNK/SAPK和p38的差异激活:“两次打击”假说

Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.

作者信息

Zhu X, Castellani R J, Takeda A, Nunomura A, Atwood C S, Perry G, Smith M A

机构信息

Institute of Pathology, Case Western Reserve University, 2085 Adelbert Road, Cleveland, OH 44106, USA.

出版信息

Mech Ageing Dev. 2001 Dec;123(1):39-46. doi: 10.1016/s0047-6374(01)00342-6.

DOI:10.1016/s0047-6374(01)00342-6
PMID:11640950
Abstract

There are multiple lines of evidence showing that oxidative stress and aberrant mitogenic signaling play an important role in the pathogenesis of Alzheimer disease. However, the chronological relationship between these and other events associated with disease pathogenesis is not known. Given the important role that mitogen-activated protein kinase (MAPK) pathways play in both mitogenic signaling (ERK) and cellular stress signaling (JNK/SAPK and p38), we investigated the chronological and spatial relationship between activated ERK, JNK/SAPK and p38 during disease progression. While all three kinases are activated in the same susceptible neurons in mild and severe cases (Braak stages III-VI), in non-demented cases with limited pathology (Braak stages I and II), both ERK and JNK/SAPK are activated but p38 is not. However, in non-demented cases lacking any sign of pathology (Braak stage 0), either ERK alone or JNK/SAPK alone can be activated. Taken together, these findings indicate that MAPK pathways are differentially activated during the course of Alzheimer disease and, by inference, suggest that both oxidative stress and abnormalities in mitotic signaling can independently serve to initiate, but both are necessary to propagate, disease pathogenesis. Therefore, we propose that both 'hits', oxidative stress and mitotic alterations, are necessary for the progression of Alzheimer disease.

摘要

有多条证据表明氧化应激和异常的促有丝分裂信号传导在阿尔茨海默病的发病机制中起重要作用。然而,这些因素与疾病发病机制相关的其他事件之间的时间顺序关系尚不清楚。鉴于丝裂原活化蛋白激酶(MAPK)通路在促有丝分裂信号传导(ERK)和细胞应激信号传导(JNK/SAPK和p38)中均发挥重要作用,我们研究了疾病进展过程中活化的ERK、JNK/SAPK和p38之间的时间和空间关系。在轻度和重度病例(Braak分期III-VI)中,所有这三种激酶在相同的易感神经元中被激活,而在病理改变有限的非痴呆病例(Braak分期I和II)中,ERK和JNK/SAPK均被激活,但p38未被激活。然而,在无任何病理迹象的非痴呆病例(Braak分期0)中,单独的ERK或单独的JNK/SAPK均可被激活。综上所述,这些发现表明MAPK通路在阿尔茨海默病病程中被差异性激活,由此推断,提示氧化应激和有丝分裂信号传导异常均可独立引发疾病发病机制,但两者都是疾病进展所必需的。因此,我们提出氧化应激和有丝分裂改变这两个“打击”对于阿尔茨海默病的进展都是必要的。

相似文献

1
Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.阿尔茨海默病中神经元ERK、JNK/SAPK和p38的差异激活:“两次打击”假说
Mech Ageing Dev. 2001 Dec;123(1):39-46. doi: 10.1016/s0047-6374(01)00342-6.
2
Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.磷酸化丝裂原活化蛋白激酶(MAPK/ERK-P)、38 kDa蛋白激酶(p38-P)、应激激活蛋白激酶(SAPK/JNK-P)和钙/钙调蛋白依赖性激酶II(CaM激酶II)在tau蛋白病的神经元和神经胶质细胞的tau沉积物中差异表达。
J Neural Transm (Vienna). 2001;108(12):1397-415. doi: 10.1007/s007020100016.
3
Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.阿尔茨海默病中退化神经元中c-jun氨基末端激酶/应激激活蛋白激酶的激活与重新分布
J Neurochem. 2001 Jan;76(2):435-41. doi: 10.1046/j.1471-4159.2001.00046.x.
4
Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.帕金森病和路易体痴呆中活性磷酸化依赖性丝裂原活化蛋白激酶(MAPK/ERK)、应激激活蛋白激酶/c-Jun氨基末端激酶(SAPK/JNK)和p38激酶的表达
J Neural Transm (Vienna). 2001;108(12):1383-96. doi: 10.1007/s007020100015.
5
Retinoic acid selectively activates the ERK2 but not JNK/SAPK or p38 MAP kinases when inducing myeloid differentiation.维甲酸在诱导髓系分化时选择性激活ERK2,而不激活JNK/SAPK或p38丝裂原活化蛋白激酶。
In Vitro Cell Dev Biol Anim. 1999 Oct;35(9):527-32. doi: 10.1007/s11626-999-0063-z.
6
JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease.JKK1是JNK/SAPK的上游激活剂,在阿尔茨海默病中被激活。
J Neurochem. 2003 Apr;85(1):87-93. doi: 10.1046/j.1471-4159.2003.01645.x.
7
Differential activation of ERK, JNK/SAPK and P38/CSBP/RK map kinase family members during the cellular response to arsenite.亚砷酸盐细胞应答过程中ERK、JNK/SAPK和P38/CSBP/RK丝裂原活化蛋白激酶家族成员的差异激活
Free Radic Biol Med. 1996;21(6):771-81. doi: 10.1016/0891-5849(96)00176-1.
8
Acrolein activates mitogen-activated protein kinase signal transduction pathways in rat vascular smooth muscle cells.丙烯醛激活大鼠血管平滑肌细胞中的丝裂原活化蛋白激酶信号转导通路。
Mol Cell Biochem. 2002 Nov;240(1-2):83-98. doi: 10.1023/a:1020659808981.
9
Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.局灶性脑缺血后丝裂原活化蛋白激酶(MAPK/ERK)、应激激活激酶SAPK/JNK和p38及其磷酸化底物表达的早期变化。
Acta Neuropathol. 2003 May;105(5):425-37. doi: 10.1007/s00401-002-0661-2. Epub 2003 Jan 21.
10
Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis.类风湿关节炎滑膜组织和细胞中应激激活蛋白激酶、细胞外信号调节激酶、c-JUN N端激酶和p38丝裂原活化蛋白激酶的激活、差异定位及调控
Arthritis Rheum. 2000 Nov;43(11):2501-12. doi: 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K.

引用本文的文献

1
Ambroxol confers neuroprotection against scopolamine-induced Alzheimer's-like pathology by modulating oxidative stress, neuroinflammation, and cognitive deficits via Nrf-2/JNK/GSK-3β signaling pathways.氨溴索通过Nrf-2/JNK/GSK-3β信号通路调节氧化应激、神经炎症和认知缺陷,从而对东莨菪碱诱导的阿尔茨海默病样病理变化发挥神经保护作用。
Front Aging Neurosci. 2025 Jul 23;17:1607289. doi: 10.3389/fnagi.2025.1607289. eCollection 2025.
2
Alzheimer's Disease and Frontotemporal Dementia: A Review of Pathophysiology and Therapeutic Approaches.阿尔茨海默病与额颞叶痴呆:病理生理学与治疗方法综述
J Neurosci Res. 2025 May;103(5):e70046. doi: 10.1002/jnr.70046.
3
Intranasal Administration of Apelin-13 Ameliorates Cognitive Deficit in Streptozotocin-Induced Alzheimer's Disease Model via Enhancement of Nrf2-HO1 Pathways.
经鼻给予Apelin-13通过增强Nrf2-HO1通路改善链脲佐菌素诱导的阿尔茨海默病模型中的认知缺陷。
Brain Sci. 2024 May 11;14(5):488. doi: 10.3390/brainsci14050488.
4
Establishment of a novel cellular model for Alzheimer's disease in vitro studies.建立用于阿尔茨海默病体外研究的新型细胞模型。
Exp Neurol. 2024 Aug;378:114820. doi: 10.1016/j.expneurol.2024.114820. Epub 2024 May 23.
5
AD-1 Small Molecule Improves Learning and Memory Function in Scopolamine-Induced Amnesic Mice Model through Regulation of CREB/BDNF and NF-κB/MAPK Signaling Pathway.AD-1小分子通过调节CREB/BDNF和NF-κB/MAPK信号通路改善东莨菪碱诱导的失忆小鼠模型的学习和记忆功能。
Antioxidants (Basel). 2023 Mar 5;12(3):648. doi: 10.3390/antiox12030648.
6
Unraveling the links between neurodegeneration and Epstein-Barr virus-mediated cell cycle dysregulation.揭示神经退行性变与爱泼斯坦-巴尔病毒介导的细胞周期失调之间的联系。
Curr Res Neurobiol. 2022 Jun 30;3:100046. doi: 10.1016/j.crneur.2022.100046. eCollection 2022.
7
Mechanistic Insights into the Neuroprotective Potential of Sacred Trees.神圣之树的神经保护潜能的机制见解。
Nutrients. 2022 Nov 9;14(22):4731. doi: 10.3390/nu14224731.
8
Phosphorylated Tau in Alzheimer's Disease and Other Tauopathies.阿尔茨海默病和其他 Tau 病中的磷酸化 Tau。
Int J Mol Sci. 2022 Oct 25;23(21):12841. doi: 10.3390/ijms232112841.
9
Roles of in Neurodevelopment and Pathogenesis of Alzheimer Disease in a Model.在阿尔茨海默病模型中 对神经发育和发病机制的作用。
Int J Mol Sci. 2022 Oct 5;23(19):11832. doi: 10.3390/ijms231911832.
10
Efonidipine Inhibits JNK and NF-κB Pathway to Attenuate Inflammation and Cell Migration Induced by Lipopolysaccharide in Microglial Cells.依福地平抑制JNK和NF-κB信号通路以减轻脂多糖诱导的小胶质细胞炎症和细胞迁移。
Biomol Ther (Seoul). 2022 Sep 1;30(5):455-464. doi: 10.4062/biomolther.2022.076. Epub 2022 Aug 22.